FR2880020B1 - NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE - Google Patents
NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUEInfo
- Publication number
- FR2880020B1 FR2880020B1 FR0413848A FR0413848A FR2880020B1 FR 2880020 B1 FR2880020 B1 FR 2880020B1 FR 0413848 A FR0413848 A FR 0413848A FR 0413848 A FR0413848 A FR 0413848A FR 2880020 B1 FR2880020 B1 FR 2880020B1
- Authority
- FR
- France
- Prior art keywords
- cosmetics
- human medicine
- rar receptors
- ligands
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0413848A FR2880020B1 (fr) | 2004-12-23 | 2004-12-23 | NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
KR1020077014372A KR101316992B1 (ko) | 2004-12-23 | 2005-12-21 | Rar 수용체를 조절하는 신규 리간드, 및 인간 의학 및화장품에서의 그의 용도 |
AU2005318292A AU2005318292B2 (en) | 2004-12-23 | 2005-12-21 | Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics |
MX2007007696A MX2007007696A (es) | 2004-12-23 | 2005-12-21 | Compuestos ligandos moduladores de los receptores nucleares del acido retinoico(rars) y uso en medicina humana y en cosmeticos. |
SI200531509T SI1831149T1 (sl) | 2004-12-23 | 2005-12-21 | Novi ligandi, ki modulirajo RAR receptorje in njihova uporaba v humani medicini in v kozmetiki |
DK05824484.9T DK1831149T3 (da) | 2004-12-23 | 2005-12-21 | Hidtil ukendte ligander, der modulerer rar-receptorer, og anvendelse deraf i human medicin og i kosmetik |
CN2005800447781A CN101087752B (zh) | 2004-12-23 | 2005-12-21 | 调节rar受体的新配体,及其在人类药品和化妆品中的用途 |
JP2007547399A JP5258299B2 (ja) | 2004-12-23 | 2005-12-21 | Rar受容体を調節する新規リガンド、並びにヒトの医薬品及び化粧品におけるその使用 |
ES05824484T ES2380777T3 (es) | 2004-12-23 | 2005-12-21 | Nuevos ligandos que modulan los receptores RAR y su uso en la medicina humana y en la cosmética |
PT05824484T PT1831149E (pt) | 2004-12-23 | 2005-12-21 | Novos ligandos que modulam recetores rar e sua utilização em medicina humana e em cosmética |
PL05824484T PL1831149T3 (pl) | 2004-12-23 | 2005-12-21 | Nowe ligandy, które modulują receptory RAR, i ich zastosowanie w medycynie i kosmetyce |
PCT/EP2005/014217 WO2006066978A1 (fr) | 2004-12-23 | 2005-12-21 | Nouveaux ligands qui modulent les recepteurs rar, et leur utilisation en medecine et en cosmetique |
AT05824484T ATE542791T1 (de) | 2004-12-23 | 2005-12-21 | Neue liganden als rar-rezeptormodulatoren und deren verwendung in der humanmedizin und kosmetik |
EP05824484A EP1831149B1 (fr) | 2004-12-23 | 2005-12-21 | Nouveaux ligands qui modulent les recepteurs rar, et leur utilisation en medecine et en cosmetique |
RU2007127867A RU2440973C3 (ru) | 2005-12-21 | Новые лиганды, модулирующие rar рецепторы, и их применение в медицине и в косметических изделиях | |
CA2590246A CA2590246C (fr) | 2004-12-23 | 2005-12-21 | Nouveaux ligands qui modulent les recepteurs rar, et leur utilisation en medecine et en cosmetique |
BRPI0517500A BRPI0517500B8 (pt) | 2004-12-23 | 2005-12-21 | composto, uso de uma composição, composição farmacêutica, composição cosmética, usos não-terapêuticos de uma composição cosmética e processo cosmético para melhorar a aparência da pele |
ARP050105474A AR055297A1 (es) | 2004-12-23 | 2005-12-22 | Ligandos moduladores de los receptores rars, utilizacion en medicina humana asi como en cosmetica |
US11/819,068 US7807708B2 (en) | 2004-12-23 | 2007-06-25 | Ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof |
ZA200705930A ZA200705930B (en) | 2004-12-23 | 2007-07-17 | Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics |
US12/842,347 US8227507B2 (en) | 2004-12-23 | 2010-07-23 | Ligands that modulate RAR receptors |
CY20121100388T CY1112721T1 (el) | 2004-12-23 | 2012-04-25 | Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα |
US13/527,299 US8470871B2 (en) | 2004-12-23 | 2012-06-19 | Ligands that modulate RAR receptors |
NL301042C NL301042I2 (nl) | 2004-12-23 | 2020-06-10 | Trifaroteen, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout |
HUS2200006C HUS2200006I1 (hu) | 2004-12-23 | 2022-02-07 | A RAR receptorokat moduláló új ligandumok, valamint alkalmazásuk humán gyógyászatban és kozmetikumokban |
LTPA2022002C LTC1831149I2 (fr) | 2004-12-23 | 2022-03-10 | |
CY2022031C CY2022031I2 (el) | 2004-12-23 | 2022-10-20 | Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0413848A FR2880020B1 (fr) | 2004-12-23 | 2004-12-23 | NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2880020A1 FR2880020A1 (fr) | 2006-06-30 |
FR2880020B1 true FR2880020B1 (fr) | 2007-02-16 |
Family
ID=34952934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0413848A Expired - Fee Related FR2880020B1 (fr) | 2004-12-23 | 2004-12-23 | NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
Country Status (12)
Country | Link |
---|---|
US (3) | US7807708B2 (fr) |
CN (1) | CN101087752B (fr) |
AR (1) | AR055297A1 (fr) |
AT (1) | ATE542791T1 (fr) |
DK (1) | DK1831149T3 (fr) |
ES (1) | ES2380777T3 (fr) |
FR (1) | FR2880020B1 (fr) |
HU (1) | HUS2200006I1 (fr) |
LT (1) | LTC1831149I2 (fr) |
PT (1) | PT1831149E (fr) |
SI (1) | SI1831149T1 (fr) |
ZA (1) | ZA200705930B (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10702604B2 (en) | 2012-06-01 | 2020-07-07 | Galderma Research & Development | Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing the same, process for preparing the same and use thereof in dermatology |
FR2991174B1 (fr) * | 2012-06-01 | 2014-12-26 | Galderma Res & Dev | Composition dermatologique comprenant des oleosomes et des retinoides, son procede de preparation et son utilisation |
FR2991171B1 (fr) * | 2012-06-01 | 2014-05-23 | Galderma Res & Dev | Procede de preparation d'une composition dermatologique comprenant des oleosomes |
FR2991176B1 (fr) * | 2012-06-01 | 2014-12-19 | Galderma Res & Dev | Compositions topiques, contenant un retinoide solubilise, de type gel hydroglycolique |
FR2991175B1 (fr) * | 2012-06-01 | 2014-12-19 | Galderma Res & Dev | Compositions pharmaceutiques topiques de type emulsion h/e contenant un retinoide |
FR2991172A1 (fr) * | 2012-06-01 | 2013-12-06 | Galderma Res & Dev | Compositions pharmaceutiques topiques comprenant des microcapsules |
JP6235294B2 (ja) * | 2013-10-07 | 2017-11-22 | 東京エレクトロン株式会社 | 基板搬送室及び容器接続機構 |
JP2016539161A (ja) | 2013-12-04 | 2016-12-15 | ガルデルマ・リサーチ・アンド・デヴェロップメント | 好ましくは親油性活性物質を含む脂質マイクロカプセル、並びにそれを含有する組成物、それらの製造のための方法、並びに皮膚科学及び化粧品におけるそれらの使用 |
US11197831B2 (en) * | 2015-05-29 | 2021-12-14 | Galderma Research And Development | Compositions comprising at least one dispersed active principle and lipid microcapsules |
CN114929678B (zh) * | 2019-11-29 | 2023-08-15 | 石家庄迪斯凯威医药科技有限公司 | 一种取代的间三联苯类化合物及其药物组合物和用途 |
WO2021216628A1 (fr) | 2020-04-21 | 2021-10-28 | Teva Pharmaceuticals International Gmbh | Formes solides de trifarotène et leur procédé de préparation |
CN115246856A (zh) * | 2021-04-27 | 2022-10-28 | 上海旭成医药科技有限公司 | 视黄酸受体激动剂、其制备方法、中间体、药物组合物和应用 |
CN113501758B (zh) * | 2021-09-10 | 2021-11-23 | 南京迈诺威医药科技有限公司 | 一种联苯化合物的制备方法 |
CN115745913B (zh) * | 2022-09-16 | 2024-05-24 | 南京迈诺威医药科技有限公司 | 曲法罗汀多晶型及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2763588B1 (fr) * | 1997-05-23 | 1999-07-09 | Cird Galderma | Composes triaromatiques, compositions les contenant et utilisations |
FR2767525B1 (fr) * | 1997-08-21 | 1999-11-12 | Cird Galderma | Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant |
-
2004
- 2004-12-23 FR FR0413848A patent/FR2880020B1/fr not_active Expired - Fee Related
-
2005
- 2005-12-21 ES ES05824484T patent/ES2380777T3/es active Active
- 2005-12-21 CN CN2005800447781A patent/CN101087752B/zh active Active
- 2005-12-21 SI SI200531509T patent/SI1831149T1/sl unknown
- 2005-12-21 DK DK05824484.9T patent/DK1831149T3/da active
- 2005-12-21 AT AT05824484T patent/ATE542791T1/de active
- 2005-12-21 PT PT05824484T patent/PT1831149E/pt unknown
- 2005-12-22 AR ARP050105474A patent/AR055297A1/es active IP Right Grant
-
2007
- 2007-06-25 US US11/819,068 patent/US7807708B2/en active Active
- 2007-07-17 ZA ZA200705930A patent/ZA200705930B/en unknown
-
2010
- 2010-07-23 US US12/842,347 patent/US8227507B2/en active Active
-
2012
- 2012-06-19 US US13/527,299 patent/US8470871B2/en active Active
-
2022
- 2022-02-07 HU HUS2200006C patent/HUS2200006I1/hu unknown
- 2022-03-10 LT LTPA2022002C patent/LTC1831149I2/lt unknown
Also Published As
Publication number | Publication date |
---|---|
US8227507B2 (en) | 2012-07-24 |
ES2380777T3 (es) | 2012-05-18 |
CN101087752A (zh) | 2007-12-12 |
US20080015246A1 (en) | 2008-01-17 |
CN101087752B (zh) | 2011-11-16 |
ATE542791T1 (de) | 2012-02-15 |
LTC1831149I2 (fr) | 2022-09-26 |
SI1831149T1 (sl) | 2012-06-29 |
PT1831149E (pt) | 2012-04-13 |
US7807708B2 (en) | 2010-10-05 |
HUS2200006I1 (hu) | 2022-03-28 |
LTPA2022002I1 (fr) | 2022-04-11 |
US20100292296A1 (en) | 2010-11-18 |
ZA200705930B (en) | 2008-07-30 |
FR2880020A1 (fr) | 2006-06-30 |
US8470871B2 (en) | 2013-06-25 |
US20120258996A1 (en) | 2012-10-11 |
AR055297A1 (es) | 2007-08-15 |
DK1831149T3 (da) | 2012-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2880020B1 (fr) | NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE | |
CY2022031I2 (el) | Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα | |
BRPI0501329A (pt) | Produto para tratamento da pele | |
FR2834718B1 (fr) | Substances actives cosmetiques et/ou pharmaceutiques | |
ATE445389T1 (de) | Liposomale glucocorticoide | |
IS8127A (is) | Aðferðir og samsetningar sem nýta ónæmistemprandiefnasambönd í meðferð og umönnun á krabba og öðrum sjúkdómum | |
TW200600117A (en) | Preparation for oral administration | |
UA88300C2 (ru) | Гидрогелевые композиции, которые содержат интерферон | |
WO2006050155A3 (fr) | Compositions therapeutiques contre le cancer | |
DE602005015694D1 (de) | Hautpflege- und kosmetisches präpart mit einem inositol-derivat | |
EP1827359A4 (fr) | Utilisation d'extraits vegetaux pour la prevention et/ou la reduction de signes de malaise subjectif et/ou d'irritation dans l'application topique de produits cosmetiques | |
FR2937972B1 (fr) | Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique | |
FR2861069B1 (fr) | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE | |
IL187469A (en) | Topical preparations containing fish gelatin, their use in cosmetic treatment and preparation | |
FR2857588B1 (fr) | Utilisation de beta-endorphine, d'agents exercant une activite beta-endorphine-like en cosmetique et dermatologie | |
FR2855409B1 (fr) | Composition cosmetique pour le maquillage et/ou le soin de la peau, notamment du visage. | |
FR2863266B1 (fr) | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINES HUMAINE AINSI QU'EN COSMETIQUE | |
WO2005094790A8 (fr) | Formulations liposomales | |
FR2855410B1 (fr) | Composition cosmetique pour le maquillage et/ou le soin de la peau, notamment du visage. | |
FR2917087B1 (fr) | Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique. | |
FR2857222B1 (fr) | Microbicide antiseptique, et cosmetique, medicament et aliment incorporant ledit microbicide antiseptique | |
FR2827861B1 (fr) | Derives des indazoles ou des indoles, leur utilisation en medecine humaine et plus particulierement en cancerologie | |
FR2847251B1 (fr) | NOUVEAUX COMPOSES BI-AROMATIQUES ACTIVEURS DES RECEPTEURS DE TYPE PPARy ET LEUR UTILISATION DANS DES COMPOSITIONS COSMETIQUES OU PHARMACEUTIQUES | |
FR2874378B1 (fr) | Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar et leur utilisation dans des compositions cosmetiques ou pharmaceutiques | |
AU2003271016A1 (en) | Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CA | Change of address | ||
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
ST | Notification of lapse |
Effective date: 20200906 |